- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
R2 Technology to sell ImageChecker in Japan
Mammography computer-aided detection firm R2 Technology’s ImageChecker CAD unit has received approval from the Japanese Ministry of Health and Welfare for use in breast cancer screening in Japan. The unit will be distributed by R2’s partner,
Mammography computer-aided detection firm R2 Technologys ImageChecker CAD unit has received approval from the Japanese Ministry of Health and Welfare for use in breast cancer screening in Japan. The unit will be distributed by R2s partner, Marubeni America, with which R2 signed an agreement last spring (SCAN 6/23/99).
The MHWs decision came as more good news for the Los Altos, CA, company, which is seeing its efforts to establish industry alliances pay off. In 1998, R2 signed an exclusive OEM supply deal with GE Medical Systems of Milwaukee. GE agreed to bundle ImageChecker with the full-field digital mammography system it had under development (SCAN 4/29/98). With the Food and Drug Administrations Jan. 31 approval of GEs Senographe (see story, page 5), R2 comes closer to bringing a digital version of ImageChecker to market.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,00 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
